End-tidal carbon monoxide and hemolysis

Journal of Perinatology

Volumn 34, Issue 8, 2014, Pages 577-581

  Tidmarsh, G F ^a   Wong, R J ^a   Stevenson, D K ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; CARBON MONOXIDE; CARBOXYHEMOGLOBIN; HEMOPROTEIN;

ARTICLE; BILIRUBIN BINDING; BILIRUBIN BLOOD LEVEL; BILIRUBIN METABOLISM; CARBON MONOXIDE BLOOD LEVEL; COOMBS TEST; DISEASE ASSOCIATION; END TIDAL CARBON MONOXIDE; HEMOGLOBIN BLOOD LEVEL; HEMOLYSIS; HUMAN; HYPERBILIRUBINEMIA; JAUNDICE; OXIDATIVE STRESS; PATHOGENESIS; PROTEIN DEGRADATION; RESPIRATORY TRACT PARAMETERS; RISK ASSESSMENT; BREATH ANALYSIS; HYPERBILIRUBINEMIA, NEONATAL; METABOLISM; NEWBORN; PHYSIOLOGY; TIDAL VOLUME;

BREATH TESTS; CARBON MONOXIDE; HEMOLYSIS; HUMANS; HYPERBILIRUBINEMIA, NEONATAL; INFANT, NEWBORN; TIDAL VOLUME;

EID: 84905275784     PISSN: 07438346     EISSN: 14765543     Source Type: Journal    
DOI: 10.1038/jp.2014.66     Document Type: Article

References (38)

1. Slusher TM, Zipursky A, Bhutani VK. A global need for affordable neonatal jaundice technologies. Semin Perinatol 2011; 35: 185-191.
2. Bhutani VK, Johnson L. A proposal to prevent severe neonatal hyperbilirubinemia and kernicterus. J Perinatol 2009; 29(Suppl 1): S61-S67.
3. Shapiro SM. Definition of the clinical spectrum of kernicterus and bilirubininduced neurologic dysfunction (BIND). J Perinatol 2005; 25: 54-59.
4. Shapiro SM, Bhutani VK, Johnson L. Hyperbilirubinemia and kernicterus. Clin Perinatol 2006; 33: 387-410.
5. Shapiro SM, Nakamura H. Bilirubin and the auditory system. J Perinatol 2001; 21 (Suppl 1): S52-S55.
6. Newman TB, Liljestrand P, Jeremy RJ, Ferriero DM, Wu YW, Hudes ES et al. Outcomes among newborns with total serum bilirubin levels of 25mg per deciliter or more. N Engl J Med 2006; 354: 1889-1900.
7. Kuzniewicz M, Newman TB. Interaction of hemolysis and hyperbilirubinemia on neurodevelopmental outcomes in the collaborative perinatal project. Pediatrics 2009; 123: 1045-1050.
8. American Academy of Pediatrics. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2004; 114: 297-316.
9. Ahlfors CE, Wennberg RP. Bilirubin-albumin binding and neonatal jaundice. Semin Perinatol 2004; 28: 334-339.
10. Brito MA, Rosa AI, Falcao AS, Fernandes A, Silva RF, Butterfield DA et al. Unconjugated bilirubin differentially affects the redox status of neuronal and astroglial cells. Neurobiol Dis 2008; 29: 30-40.
11. Cesaratto L, Calligaris SD, Vascotto C, Deganuto M, Bellarosa C, Quadrifoglio F et al. Bilirubin-induced cell toxicity involves PTEN activation through an APE1/ Ref-1-dependent pathway. J Mol Med (Berl) 2007; 85: 1099-1112.
12. Ikonomidou C, Kaindl AM. Neuronal death and oxidative stress in the developing brain. Antioxid Redox Signal 2011; 14: 1535-1550.
13. Nielsen MJ, Petersen SV, Jacobsen C, Oxvig C, Rees D, Moller HJ et al. Haptoglobinrelated protein is a high-affinity hemoglobin-binding plasma protein. Blood 2006; 108: 2846-2849.
14. Rother RP, Bell L, Hillmen P, Gladwin MT. The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease. JAMA 2005; 293: 1653-1662.
15. Exner M, Minar E, Wagner O, Schillinger M. The role of heme oxygenase-1 promoter polymorphisms in human disease. Free Rad Biol Med 2004; 37: 1097-1104.
16. Maisels MJ, Gifford K, Antle CE, Leib GR. Jaundice in the healthy newborn infant: a new approach to an old problem. Pediatrics 1988; 81: 505-511.
17. Newman TB, Easterling MJ. Yield of reticulocyte counts and blood smears in term infants. Clin Pediatr 1994; 33: 71-76.
18. Berk PD, Rodkey FL, Blaschke TF, Collison HA, Waggoner JG. Comparison of plasma bilirubin turnover and carbon monoxide production in man. J Lab Clin Med 1974; 83: 29-37.
19. Sjostrand T. A practical method for estimating carboxyhaemoglobin by alveolar air analysis. Overseas Postgrad Med J 1948; 2: 485-487.
20. Sjostrand T. Endogenous formation of carbon monoxide in man. Nature 1949; 164: 580.
21. Vreman HJ, Knauer Y, Wong RJ, Chan ML, Stevenson DK. Dermal carbon monoxide excretion in neonatal rats during light exposure. Pediatr Res 2009; 66: 66-69.
22. Vreman HJ, Wong RJ, Sanesi CA, Dennery PA, Stevenson DK. Simultaneous production of carbon monoxide and thiobarbituric acid reactive substances in rat tissue preparations by an iron-ascorbate system. Can J Physiol Pharmacol 1998; 76: 1057-1065.
23. Vreman HJ, Mahoney JJ, Stevenson DK. Carbon monoxide and carboxyhemoglobin. Adv Pediatr 1995; 42: 303-334.
24. Vreman HJ, Stevenson DK, Oh W, Fanaroff AA, Wright LL, Lemons JA et al. Semiportable electrochemical instrument for determining carbon monoxide in breath. Clin Chem 1994; 40: 1927-1933.
25. Stevenson DK, Vreman HJ, Oh W, Fanaroff AA, Wright LL, Lemons JA et al. Bilirubin production in healthy term infants as measured by carbon monoxide in breath. Clin Chem 1994; 40: 1934-1939.
26. Vreman HJ, Baxter LM, Stone RT, Stevenson DK. Evaluation of a fully automated endtidal carbon monoxide instrument for breath analysis. Clin Chem 1996; 42: 50-56.
27. Vreman HJ, Wong RJ, Harmatz P, Fanaroff AA, Berman B, Stevenson DK. Validation of the Natus CO-Stat End Tidal Breath Analyzer in children and adults. J Clin Monit Comput 1999; 15: 421-427.
28. Vreman HJ, Mahoney JJ, Van Kessel AL, Stevenson DK. Carboxyhemoglobin as measured by gas chromatography and with the IL 282 and 482 CO-Oximeters. Clin Chem 1988; 34: 2562-2566.
29. Javier MC, Krauss A, Nesin M. Corrected end-tidal carbon monoxide closely correlates with the corrected reticulocyte count in coombs' test-positive term neonates. Pediatrics 2003; 112: 1333-1337.
30. Stevenson DK, Fanaroff AA, Maisels MJ, Young BW, Wong RJ, Vreman HJ et al. Prediction of hyperbilirubinemia in near-term and term infants. Pediatrics 2001; 108: 31-39.
31. Herschel M, Karrison T, Wen M, Caldarelli L, Baron B. Evaluation of the direct antiglobulin (Coombs') test for identifying newborns at risk for hemolysis as determined by end-tidal carbon monoxide concentration (ETCOc); and comparison of the Coombs' test with ETCOc for detecting significant jaundice. J Perinatol 2002; 22: 341-347.
32. Barak M, Oron T, Mimouni FB, Dollberg S, Littner Y. Effect of hematocrit on exhaled carbon monoxide in healthy newborn infants. J Perinatol 2005; 25: 784-787.
33. Herschel M, Ryan M, Gelbart T, Kaplan M. Hemolysis and hyperbilirubinemia in an African American neonate heterozygous for glucose-6-phosphate dehydrogenase deficiency. J Perinatol 2002; 22: 577-579.
34. Kaplan M, Herschel M, Hammerman C, Hoyer JD, Stevenson DK. Hyperbilirubinemia among African American, glucose-6-phosphate dehydrogenasedeficient neonates. Pediatrics 2004; 114: e213-e219.
35. Kaplan M, Herschel M, Hammerman C, Karrison T, Hoyer JD, Stevenson DK. Studies in hemolysis in glucose-6-phosphate dehydrogenase-deficient African American neonates. Clin Chim Acta 2006; 365: 177-182.
36. Sylvester KP, Patey RA, Rafferty GF, Rees D, Thein SL, Greenough A. Exhaled carbon monoxide levels in children with sickle cell disease. Eur J Pediatr 2005; 164: 162-165.
37. James EB, Vreman HJ, Wong RJ, Stevenson DK, Vichinsky E, Schumacher L et al. Elevated exhaled carbon monoxide concentration in hemoglobinopathies and its relation to red blood cell transfusion therapy. Pediatr Hematol Oncol 2010; 27: 112-121.
38. Blok CA, Krediet TG, Kavelaars A, Koopman-Esseboom C, Vreman HJ, Van Bel F. Early end-tidal carbon monoxide levels and neurodevelopmental outcome at 3 years 6 months of age in preterm infants. Dev Med Child Neurol 2011; 53: 1113-1118.